Home › Trial NCT01600339
A Trial of Cabazitaxel for Advanced Transitional Cell Carcinoma (TCC)
- Trial IDNCT01600339
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorRambam Health Care Campus
- Enrollment19
- Start date2012-05
- ConditionsUrothelial Carcinoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.